Morgan Stanley has initiated coverage of Onto Innovation with an overweight rating, citing potential upside to consensus estimates due to its role in semiconductor process control. Needham has rated Ceva as a buy, projecting it as a beneficiary of AI in the semiconductor industry, with a price target of $55.
UBS initiated coverage of Jade Biosciences, highlighting its potential for FDA approval based on shorter kidney function data. JPMorgan has rated Esco Technologies as overweight, noting its differentiated offerings, with a price target of $420.
Baird has identified Capital One as a fresh pick, emphasizing its strong capital position and earnings flexibility despite market concerns about consumer weakness. Bank of America initiated TeraWulf as a buy, with a price target of $34, recognizing its dual role as a bitcoin miner and data center.
Morgan Stanley upgraded Ferrari to overweight, raising its price target to $438, suggesting that brand risks are overstated. Citi upgraded Paychex to buy, anticipating growth driven by increased bookings and synergies from an acquisition. Jefferies upgraded HawkEye 360 to buy, citing a significant upside potential.
KeyBanc upgraded Rocket Lab and Firefly Aerospace, predicting strong demand for launch vehicles. Roth initiated Better Home & Finance as a buy, highlighting its AI-driven advantages in mortgage lending. TD Cowen raised its price target on Micron to $1,500 ahead of earnings, expecting strong EPS growth. Citi downgraded Old Dominion to sell and C.H.
Robinson to neutral, suggesting that optimism is already reflected in their valuations. Goldman Sachs reinstated 3M as a buy, viewing it as a self-help story with improving growth. Other notable calls include upgrades for Lincoln International, Datadog, and downgrades for Roku and several trucking companies.
Overall, these analyst calls reflect a mix of optimism and caution across various sectors, providing investors with insights into potential opportunities and risks